Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

189 Results

Guidelines and Advice

Focal Tumor Ablation: Thermal Ablation of Hepatocellular Carcinoma and Metastases from Colorectal Carcinoma

Status: In-Review
ID: FA 1

Jul 2014

Guidelines and Advice

The Utility of PET/CT in Colorectal Cancer Metastasis: An Evidence Summary

Status: Current
ID: PET ES-15

Jan 2014

Guidelines and Advice

The Utility of PET/CT in Breast Cancer (Stages II-IV): An Evidence Summary

Status: Current
ID: PET ES-14

Jan 2014

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2014

Status: Current
ID: PET 2014-1

Dec 2014

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to Dec 2013

Status: Current
ID: PET 2013-2

Sep 2014

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July 2012 to June 2013

Status: Current
ID: PET 2013-1

May 2014

Guidelines and Advice

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Status: In-Review
ID: 7-9
Version: 2

Apr 2014

Guidelines and Advice

The Use of Indoor Tanning Devices and the Risk of Developing Cutaneous Malignant Melanoma: A Systematic Review and Clinical Practice Guideline

Status: Current
ID: 8-8

Aug 2014

Guidelines and Advice

Optimization of Preoperative Assessment in Patients Diagnosed With Rectal Cancer

Status: Current
ID: 17-8

Jan 2014

Guidelines and Advice

Active Surveillance for the Management of Localized Prostate Cancer

Status: Current
ID: 17-9

Dec 2014

Guidelines and Advice

Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Status: Current
ID: GL 4-1
Version: 2

Jan 2021

Guidelines and Advice

Screening Postmenopausal Women for Ovarian Cancer

Status: Archived
ID: 4-6a

Jan 2014

Pages